New Products: Asper Biotech's Ashkenazi Jewish Diseases Test | GenomeWeb

Asper Biotech has updated its Ashkenazi Jewish Diseases Test to include mutations in the BRCA1, BRCA2, and LCA5 genes that are common in the Ashkenazi Jewish population. Asper's test now detects up to 112 variants in 27 genes. The test is run using arrayed primer extension and enables the analysis of the most common mutations associated with severe disorders in the Ashkenazi Jewish population, such as cystic fibrosis, Tay-Sachs disease, maple syrup urine disease, and others.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.